MedPath

A study of patchy hair loss(alopecia areata) by local examination and using an instrument (dermoscope) and a study of effectiveness of an applicant called Diphenycyprone

Phase 4
Conditions
Health Condition 1: L639- Alopecia areata, unspecifiedHealth Condition 2: L639- Alopecia areata, unspecified
Registration Number
CTRI/2019/04/018380
Lead Sponsor
Yenepoya Medical College
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

All patients visiting Yenepoya medical college hospital during the study period with a clinical diagnosis of alopecia areata voluntarily consenting to participate in the study

For the Diphencyprone treatment group: Patients who have failed any one form of treatment for alopecia areata and those willing for regular follow up.

Exclusion Criteria

Patient with immunocompromised status, pregnancy, lactating mothers, severe systemic illnesses

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. Determining clinical profile of Alopecia areata <br/ ><br>2. Determining the Dermoscopic featuresTimepoint: 18 months
Secondary Outcome Measures
NameTimeMethod
Efficacy of Diphencyprone in Alopecia areataTimepoint: 12 WEEKS
© Copyright 2025. All Rights Reserved by MedPath